Viatris (VTRS) Capital Expenditures (2020 - 2026)

Viatris (VTRS) recorded quarterly Capital Expenditures of $39.9 million in Q1 2026, down 79.69% quarter-over-quarter from $196.5 million in Q4 2025, and down 6.34% on a YoY basis from $42.6 million in Q1 2025.

Viatris (VTRS) Capital Expenditures (2020 - 2026) Analysis & Trends

Viatris' Capital Expenditures history runs 7 years deep, the most recent figure standing at $39.9 million for Q1 2026.

  • In Q1 2026, Capital Expenditures fell 6.34% year-over-year to $39.9 million; the TTM figure through Mar 2026 stood at $376.1 million (up 17.97% YoY), while the FY2025 annual figure was $378.8 million, up 16.2% from the prior year.
  • Capital Expenditures was $39.9 million for Q1 2026 at Viatris, down from $196.5 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $196.5 million in Q4 2025 to a low of $39.9 million in Q1 2026.
  • Historically, Capital Expenditures has averaged $89.9 million across 5 years, with a median of $77.0 million in 2024.
  • The sharpest annual moves came in 2023 and 2025: Capital Expenditures retreated 25.89% in 2023, then surged 39.96% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at $153.7 million in 2022, then advanced by 7.68% to $165.5 million in 2023, then fell by 15.17% to $140.4 million in 2024, then surged by 39.96% to $196.5 million in 2025, then slumped by 79.69% to $39.9 million in 2026.
  • The last three Capital Expenditures figures came in at $39.9 million (Q1 2026), $196.5 million (Q4 2025), and $86.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 168.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 110.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 100.80 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 9.10 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 51.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 4.09 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 8.83 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 2.04 Mn
10 Viatris - - 1.16 Bn 39.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 39.90 Mn
Mar 31, 2026 39.90 Mn
Dec 31, 2025 196.50 Mn
Dec 31, 2025 196.50 Mn
Sep 30, 2025 86.80 Mn
Sep 30, 2025 86.80 Mn
Jun 30, 2025 52.90 Mn
Jun 30, 2025 52.90 Mn
Mar 31, 2025 42.60 Mn
Mar 31, 2025 42.60 Mn
Dec 31, 2024 140.40 Mn
Dec 31, 2024 140.40 Mn
Sep 30, 2024 77.00 Mn
Sep 30, 2024 77.00 Mn
Jun 30, 2024 58.80 Mn
Jun 30, 2024 58.80 Mn
Mar 31, 2024 49.80 Mn
Mar 31, 2024 49.80 Mn
Dec 31, 2023 165.50 Mn
Dec 31, 2023 165.50 Mn